Moreover, like other ORs, activating the κOR promotes antinociception, and κOR agonists produce an analgesic effect without respiratory depression that is often seen with μOR agonists [22]. The gene discussed is OPRK1; the disease is Respiratory insufficiency due to muscle weakness.